Aurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in Europe

Hyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, CuraTeQ Biologics Pvt Ltd, has entered into a marketing and distribution agreement with Germany-based pharmaceutical company STADA Arzneimittel AG…

Continue ReadingAurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in Europe

JB Chemicals Appoints Aman Mehta as MD, Expands Board with Three New Directors

Mumbai: J.B. Chemicals & Pharmaceuticals Limited has announced key changes to its board following shareholder approval via postal ballot, reinforcing its leadership structure and governance framework. The company has appointed…

Continue ReadingJB Chemicals Appoints Aman Mehta as MD, Expands Board with Three New Directors

Semaglutide Misuse Under Watch: Telangana DCA Issues Advisory After Generic Launch Surge

New Delhi: In response to the growing demand and widespread use of Semaglutide formulations following the patent expiry of innovator products in March 2026, the Drugs Control Administration (DCA), Telangana,…

Continue ReadingSemaglutide Misuse Under Watch: Telangana DCA Issues Advisory After Generic Launch Surge

State Drug Alert: From Antibiotics to Antihypertensives, 134 Samples Found NSQ in February Audit

New Delhi: Reflecting ongoing concerns over drug quality in India, the Central Drugs Standard Control Organisation (CDSCO) has flagged 134 drug samples as Not of Standard Quality (NSQ) in its…

Continue ReadingState Drug Alert: From Antibiotics to Antihypertensives, 134 Samples Found NSQ in February Audit

Warburg Pincus in Talks to Acquire Maneesh Pharma’s Doxinate Portfolio in Rs 1,800 Cr Deal: Report

Mumbai: The US-based private equity firm Warburg Pincus is in advanced discussions to acquire the formulations business of Maneesh Pharmaceuticals in a deal estimated to be valued at around Rs…

Continue ReadingWarburg Pincus in Talks to Acquire Maneesh Pharma’s Doxinate Portfolio in Rs 1,800 Cr Deal: Report